Cancer Guide Blog: Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Tamoxifen Resistant Breast Cancer New Reason Found
http://www.medicalnewstoday.com/articles/127571.php
A US study found a new way in which breast cancer becomes resistant to tamoxifen, the most widely sold drug for breast cancer prevention and treatment throughout the world. The researchers suggest this could be an early way to spot patients who are not responding to tamoxifen and give doctors time to find an alternative treatment sooner.

Patient Strategies Identified For Managing Symptoms Of Lymphedema
http://www.medicalnewstoday.com/articles/127477.php
An estimated 2 million women in the United States are at risk of developing lymphedema, a condition that involves the chronic and abnormal swelling of the arm, chest, neck and/or back, as a complication of breast cancer treatment.

----------------------------------------------
** CANCER / ONCOLOGY News **

ImClone Announces ERBITUX(R) Commercial Launch In Canada For Advanced Colorectal Cancer
http://www.medicalnewstoday.com/articles/127555.php
ImClone Systems Incorporated (NASDAQ: IMCL) today announced the commercial launch of ERBITUX® (cetuximab) in Canada for use in the treatment of metastatic colorectal cancer (mCRC). Bristol-Myers Squibb collaborates with ImClone on ERBITUX in North America and is making the product commercially available through its wholly-owned subsidiary Bristol-Myers Squibb Canada.

Cancer Prevention: The Upside To Allergies
http://www.medicalnewstoday.com/articles/127484.php
A new article in the December issue of <i>The Quarterly Review of Biology</i> provides strong evidence that allergies are much more than just an annoying immune malfunction. They may protect against certain types of cancer.

Discovery Of New Eph Receptor Tyrosine Kinase Overexpressed In Gastric Cancer
http://www.medicalnewstoday.com/articles/127456.php
The potential role of Eph receptor and ephrin ligand family in human cancer is receiving increasing attention. Compared with other Eph receptors, EphA4 is distinguished by its ability to bind to both type A ephrins and most type B ephrins.

A Potential Target For The Prevention Or Treatment Of Esophageal Carcinoma
http://www.medicalnewstoday.com/articles/127453.php
Expression of Livin in fresh esophageal cancer tissues was detected by immunohistochemistry (IHC), Western blotting and reverse transcriptase-polymerase chain reaction (RT-PCR), VEGF by Its correlation Western blotting and RT-PCR.

Candidate Markers For Gastric Cancer
http://www.medicalnewstoday.com/articles/127449.php
The sequencing of the human genome has opened the door for proteomics by providing a sequence-based framework for mining proteomes. As a result, there is intense interest in applying proteomics to foster a better understanding of cancer processes, develop new biomarkers for diagnosis and early detection of cancer.

Does Diabetes Have A Direct Carcinogenetic Effect?
http://www.medicalnewstoday.com/articles/127448.php
The association of DM2 with solid tumors, and particularly with HCC, has been long suspected and several studies have reported increased mortality rates for neoplastic diseases in patients with DM2.

Severe Gestational Hypertension May Protect Against Testicular Cancer
http://www.medicalnewstoday.com/articles/127446.php
Women who experience severe gestational hypertension may give birth to boys at lower risk for testicular cancer, although the exact reasons why are still unclear, according to a paper published in the November 1, 2008, issue of <a href="http://cancerres.

Jefferson Department Of Surgery Announces New Pancreas Tumor Registry
http://www.medicalnewstoday.com/articles/127419.php
Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, announces the establishment of the new Jefferson Pancreas Tumor Registry (JPTR).

Rexin-G Returns To The Big Apple: Clinical Trials For Pancreatic Cancer And Breast Cancer Open In Manhattan
http://www.medicalnewstoday.com/articles/127407.php
Epeius Biotechnologies Corporation announced the expansion of clinical trials using intravenous Rexin-G for pancreatic cancer and breast cancer in Manhattan, New York. Rexin-G is the world's first tumor-targeted genetic medicine that is designed to seek out and destroy both primary tumors and metastatic cancers that have spread throughout the body.

DPH Announces Database On Cancer Incidence And Mortality Rates For Connecticut Now Available Online
http://www.medicalnewstoday.com/articles/127400.php
The Connecticut Department of Public Health (DPH) today announced an online database on cancer incidence and mortality rates for Connecticut and each of the eight counties in Connecticut. The<i> "Cancer Incidence and Mortality in Connecticut"</i> resource produces tables with cancer rates for each of the state's counties, and county maps colored according to the range of cancer rates for each type of cancer.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **